Microbiota of the gastrointestinal tract: Friend or foe?

World J Gastroenterol. 2023 Jan 7;29(1):19-42. doi: 10.3748/wjg.v29.i1.19.

Abstract

The gut microbiota is currently considered an external organ of the human body that provides important mechanisms of metabolic regulation and protection. The gut microbiota encodes over 3 million genes, which is approximately 150 times more than the total number of genes present in the human genome. Changes in the qualitative and quantitative composition of the microbiome lead to disruption in the synthesis of key bacterial metabolites, changes in intestinal barrier function, and inflammation and can cause the development of a wide variety of diseases, such as diabetes, obesity, gastrointestinal disorders, cardiovascular issues, neurological disorders and oncological concerns. In this review, I consider issues related to the role of the microbiome in the regulation of intestinal barrier function, its influence on physiological and pathological processes occurring in the body, and potential new therapeutic strategies aimed at restoring the gut microbiome. Herewith, it is important to understand that the gut microbiota and human body should be considered as a single biological system, where change of one element will inevitably affect its other components. Thus, the study of the impact of the intestinal microbiota on health should be considered only taking into account numerous factors, the role of which has not yet been fully elucidated.

Keywords: Bacterial metabolites; Dysbiosis; Fecal microbiota transplantation; Gut microbiota; Intestinal barrier; Probiotics.

Publication types

  • Review

MeSH terms

  • Dysbiosis / microbiology
  • Gastrointestinal Diseases* / microbiology
  • Gastrointestinal Microbiome* / physiology
  • Humans
  • Inflammation / microbiology
  • Microbiota*
  • Probiotics*